Incidence rates for adenocarcinomas of the esophagus and gastric cardia have risen steeply over the last few decades. To determine risk factors for these tumors, we conducted a multicenter, population-based, case-control study. Methods: The study included 554 subjects newly diagnosed with esophageal or gastric cardia adenocarcinomas, 589 subjects newly diagnosed with esophageal squamous cell carcinoma or other gastric adenocarcinomas, and 695 control subjects. Estimates of risk (odds ratios [ORs] and corresponding 95% confidence intervals [CIs]) were calculated for the four tumor types separately and for esophageal and gastric cardia adenocarcinomas combined. Results: Risk of esophageal and gastric cardia adenocarcinomas combined was increased among current cigarette smokers (OR = 2.4; 95% = 1.7-3.4), with little reduction observed until 30 years after smoking cessation; this risk rose with increasing intensity and duration of smoking. Risk of these tumors was not related to beer (OR = 0.8; 95% CI = 0.6-1.1) or liquor (OR = 1.1; 95% CI = 0.8-1.4) consumption, but it was reduced for drinking wine (OR = 0.6; 95% CI = 0.5-0.8). Similar ORs were obtained for the development of noncardia gastric adenocarcinomas in relation to tobacco and alcohol use, but higher ORs were obtained for the development of esophageal squamous cell carcinomas. For all four tumor types, risks were higher among those with low income or education. Conclusions: Smoking is a major risk factor for esophageal and gastric cardia adenocarcinomas, accounting for approximately 40% of cases. Implications: Because of the long lag time before risk of these tumors is reduced among exsmokers, smoking may affect early stage carcinogenesis. The increase in smoking prevalence during the first two thirds of this century may be reflected in the rising incidence of these tumors in the past few decades among older individuals. The recent decrease in smoking may not yet have had an impact.
The incidence rates for adenocarcinomas of the esophagus and gastric cardia have risen steeply in the United States and Europe during the past few decades, whereas the incidence of squamous cell carcinoma of the esophagus and of adenocarcinomas located elsewhere in the stomach have remained stable or have decreased during this time period (1) (2) (3) (4) (5) . Incidence rates for esophageal and gastric cardia adenocarcinomas are highest among white males, while rates for esophageal squamous cell carcinoma and noncardia gastric adenocarcinomas are highest among black males (1, 3) . The reasons underlying these contrasting patterns of incidence are unclear.
Tobacco smoking and alcohol use are strong risk factors for esophageal squamous cell carcinoma (6) , whereas smoking is only weakly related to adenocarcinomas in the lower stomach (7) . Several studies (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) have reported only a slight excess in risk of esophageal or gastric cardia adenocarcinomas associated with smoking and drinking. It has been suggested that patients with adenocarcinomas of the esophagus and gastric cardia have a higher income and more years of education than those with esophageal squamous cell carcinoma or noncardia gastric adenocarcinomas (2, 13, 15) .
Esophageal adenocarcinomas are often located in the lower third of the esophagus near the gastroesophageal junction, and distinguishing adenocarcinomas arising in the lower esophagus from those arising in the gastro-esophageal junction are often very difficult (19, 20) . Tumors arising in the gastro-esophageal junction itself are classified by the Surveillance, Epidemiology, and End Results (SEER) 1 Program as being located in the gastric cardia (21) .
Because of similar incidence patterns and anatomic proximity, it has been hypothesized that the origins of esophageal and gastric cardia adenocarcinomas are similar to one another and are distinct from the causes of esophageal squamous cell carcinoma and other gastric adenocarcinomas (3) . To clarify this issue, we undertook a large collaborative, population-based study to identify risk factors for adenocarcinomas of the esophagus and gastric cardia. For comparison, we also determined risk factors for squamous cell carcinoma of the esophagus and noncardia adenocarcinomas of the stomach.
Subjects and Methods
This multicenter, case-control study was conducted in three geographic areas of the United States with population-based tumor registries-the state of Connecticut, a 15-county area of New Jersey, and a three-county area of western Washington state. The goal of the collaborative effort was to identify, recruit, and interview four population-based case groups of roughly equal size containing subjects newly diagnosed with 1) esophageal adenocarcinoma, 2) gastric cardia adenocarcinoma, 3) esophageal squamous cell carcinoma, or 4) other gastric adenocarcinomas. The investigation was performed after approval from our institutional review boards and in accord with an assurance filed with and approved by the U.S. Department of Health and Human Services.
Potentially eligible case subjects were English-speaking men and women who were 30-79 years of age and who were diagnosed with primary invasive cancer of the esophagus or stomach from February 1, 1993 , through January 31, 1995, in Connecticut; from April 1, 1993 , through November 30, 1994 , in New Jersey; and from March 1, 1993, through February 28, 1995, in Washington. All case subjects diagnosed with adenocarcinomas of the esophagus or gastric cardia (target case subjects) were considered eligible for the study. Those diagnosed with squamous cell carcinoma of the esophagus or adenocarcinomas located elsewhere in the stomach (comparison case subjects) were sampled by frequency matching to the expected distribution of the target case subjects on the basis of geographic area and 5-year age group in Connecticut, New Jersey, and Washington; on the basis of sex in New Jersey and Washington; and on the basis of race (white or other) in New Jersey.
All case subjects were identified by use of established rapid-reporting systems. Pathology reports were obtained for all potentially eligible case patients, and initial subject selection was based on the review of these records. Patients with tumors classified as not otherwise specified (NOS), mixed, or undifferentiated or with tumors of uncertain histologic type were initially considered eligible and approached for study participation, as were those with tumors in an unspecified subsite of the stomach. Final determination of case subject eligibility was based on a systematic review by the study pathologists (H. Rotterdam for New Jersey and A. B. West for Connecticut and Washington) using standardized criteria. The site of tumor origin was determined by a review of pathology slides and medical records, including pathology, radiology, surgery, and endoscopy reports. For tumors that involved the distal esophagus as well as the gastric cardia or proximal stomach, the site of origin was determined by estimating the location of the tumor's center using endoscopic, surgical, and pathologic data. Histologic slides of diagnostic biopsy and resection specimens and slides of tumor brushings and other cytologic preparations were reviewed in more than 99% of the cases. For those patients diagnosed with an indeterminate site of tumor origin by the initial study pathologist, records were rereviewed by the other study pathologist; disagreements were resolved by consensus.
Population-based control subjects were frequency matched to the expected distribution of target case subjects by 5-year age group and sex. Control subjects who were 30-64 years of age were identified by use of Waksberg's randomdigit-dialing (RDD) method (22) ; those who were 65-79 years of age were identified by means of random sampling of Health Care Financing Administration (HCFA) rosters.
Face-to-face interviews were obtained for 554 (80.6%) of the eligible target case subjects, 589 (74.1%) of the eligible comparison case subjects, and 695 (73.7%) of the eligible control subjects. If the telephone screener response rate of 90.8% is taken into account for the 51.9% of control subjects who were identified by use of RDD, the overall response rate among control subjects was 70.2%. The primary reason for nonparticipation was subject refusal (12% of target case subjects, 17% of comparison case subjects, and 23.3% of control subjects), followed by physician refusal for case subjects (4% for each group). Interviews were administered directly to the study subject, rather than to the closest next of kin (usually the spouse), for 70.4% of the target case subjects, 67.8% of the comparison case subjects, and 96.6% of the control subjects. For case subjects, the mean length of time between cancer diagnosis and the interview was 3.7 months when the interview was conducted with the subject and 8.5 months when the interview was conducted with a proxy.
Prior to the interview, written informed consent was obtained from all subjects. During the interview, a structured questionnaire was administered by trained interviewers, and the average time to complete the questionnaire was 130 minutes. Information was collected on demographic characteristics, tobacco and alcohol use, other beverage consumption, medical history, use of medications, diet, and occupational history. The interview also elicited details on usual tobacco use anytime prior to 1 year before the interview, including the product type used (cigarettes, cigars, pipes, chewing tobacco, or snuff) as well as the intensity of its use, the age started and stopped, the total duration of use excluding the years stopped, and the years since last use for each type of product; for cigarette smoking, it was determined whether or not filtered cigarettes were used. A never smoker was defined as having smoked less than 100 cigarettes ever or having smoked less than one cigarette per day for 6 months or longer. An ex-smoker was defined as having stopped smoking 2 or more years before the interview. Alcohol consumption patterns were assessed by inquiring about the usual intake anytime prior to 1 year before the interview for each type of beverage separately, i.e., beer, wine, or liquor. A never drinker was defined as having consumed less than one drink per month. One drink was defined as 12 ounces of beer, 4 ounces of wine, or 1 ounce of hard liquor. The three types of alcohol were also combined to form an overall estimate of use.
Unconditional logistic regression was used to calculate odds ratios (ORs), as an estimate of the relative risk, and corresponding 95% confidence intervals (CIs) (23) for each of the four tumor types (esophageal adenocarcinoma, gastric cardia adenocarcinoma, esophageal squamous cell carcinoma, and other gastric adenocarcinomas) and for the combined category of esophageal and gastric cardia adenocarcinomas in relation to tobacco, alcohol, education, and income. All models included as covariates the frequency-matched factors of geographic center (Connecticut/Washington/New Jersey, entered as indicator variables), age (in quartiles and entered as indicator variables), sex (female/male), and race (white/black/other, entered as indicator variables).
Logistic regression models were also used to adjust for the confounding effects of body mass index (BMI; expressed as weight in kilograms divided by the square of height in meters) (entered as a continuous variable) and income (entered as an ordered categoric variable). The 5% of persons with missing information on income were assigned values derived from simple regression models for case and control subjects that included age, race, sex, and education. Omission of subjects with missing income information from the logistic models did not materially alter the estimates of effect for tobacco, alcohol, education, or income. Inclusion of the imputed variables for these persons, however, permitted more precise estimates to be calculated for small subgroups of interest. Therefore, results from models that included all subjects are presented. In models that adjusted for the confounding effects of cigarette smoking, the factor was entered as an indicator variable (current smoker/ex-smoker/nonsmoker). Similarly, to adjust for the confounding effects of beer, hard liquor, and wine, each factor was entered as a dichotomous variable (ever/never). Subject characteristics that did not confound our results include education, family history of cancer, history of other medical conditions such as ulcers, use of various medications, and caloric intake.
Tests for trend in the ORs across exposure strata were calculated using logistic models that included continuous variables and, where appropriate, omitted never users. Potential effect modification between smoking and alcohol use or with other variables, such as age, sex, center, and race, was evaluated assuming a multiplicative model using logistic regression with cross-product terms representing the interaction between the two variables.
ORs and corresponding CIs derived from polytomous logistic regression models (23) for the four tumor types were nearly identical to those obtained from standard unconditional logistic regression. Thus, only the values obtained from the latter method are shown.
To compare two continuous variables, Pearson's correlation coefficient was calculated (24) . Population attributable risk estimates were calculated (25) . All reported P values are from two-sided tests. Table 1 shows the distribution of study participants according to demographic characteristics. Approximately 98% of the case subjects with esophageal and gastric cardia adenocarcinomas were white and 85% were males, whereas the corresponding percentages were 93% and 80% for the control subjects and 81% and 73% for the comparison case subjects. The median age at diagnosis was 66 years, with the case subjects being slightly older on average than the control subjects. About half of the study participants were from New Jersey (46.5%), while 30.9% were from Connecticut and 22.6% were from Washington. Table 2 shows the estimates of risk according to tumor type in relation to indicators of socioeconomic status. A decrease in risk for all types was noted with increasing levels of education or income; the inverse association with income was most pronounced for esophageal squamous cell carcinoma. The adjusted (for age, sex, geographic center, race, smoking, alcohol use, BMI, and education) ORs for esophageal adenocarcinoma and for gastric cardia adenocarcinoma were 0.5 (95% CI ‫ס‬ 0.3-1.0) and 0.8 (95% CI ‫ס‬ 0.4-1.6), respectively, among respondents with incomes of $75 000 per year or more compared with those with incomes of less than $15 000. Similarly, the corresponding adjusted ORs for graduate education compared with having less than a high school diploma were 0.7 (95% CI ‫ס‬ 0.3-1.3) and 0.8 (95% CI ‫ס‬ 0.4-1.6), respectively. Pearson's correlation coefficient between income and education among control subjects was .54 (P ‫ס‬ .01). Table 3 shows the estimates of risk associated with various patterns of cigarette smoking. With adjustments made for the confounding effects of age, sex, geographic center, race, BMI, income, and alcohol use, the risk of esophageal and gastric cardia adenocarcinomas was doubled among current smokers (OR ‫ס‬ 2.2; 95% CI ‫ס‬ 1.4-3.3 and OR ‫ס‬ 2.6; 95% CI ‫ס‬ 1.7-4.0, respectively) as well as among ex-smokers (OR ‫ס‬ 2.0; 95% CI ‫ס‬ 1.4-2.9 and OR ‫ס‬ 1.9; 95% CI ‫ס‬ 1.3-2.9, respectively). An increase in risk persisted up to 30 years after cigarette use had ceased. The adjusted ORs also increased with increasing years of smoking and with the number of cigarettes smoked per day for †Reference category. ‡Two-sided test for trend; P for trend ‫ס‬ .001.
Results
both tumors, but risks were similar in users of filtered and nonfiltered cigarettes. For subjects with esophageal squamous cell carcinoma, the adjusted OR associated with current cigarette smoking was 5.1 (95% CI ‫ס‬ 2.8-9.2) but the OR dropped to 2.3 (95% CI ‫-1.1ס‬ 4.8) by 11-20 years after smoking cessation and to 1.8 (95% CI ‫ס‬ 0.8-4.2) 30 years after quitting smoking. For noncardia gastric adenocarcinomas, the ORs were 1.8 (95% CI ‫ס‬ 1.2-2.7) and 1.5 (95% CI ‫)1.2-1.1ס‬ for current and ex-smokers, respectively.
Case subjects with esophageal and gastric cardia adenocarcinomas were not more likely than control subjects or comparison case subjects to use other tobacco products, including cigars, pipes, chewing tobacco, or snuff (data not shown). Table 4 shows the ORs for alcohol intake. With adjustments made for smoking and other confounders, adenocarcinomas of the esophagus, the gastric cardia, or other gastric sites did not appear to be associated with drinking beer or hard liquor. In contrast, the risk of esophageal squamous cell carcinoma was doubled in relation to ever use of beer and tripled in relation to ever use of liquor. The risk estimates rose with increasing consumption of either product for this type of tumor. Ever drinking of wine was associated with a decreased risk of adenocarcinomas of the esophagus (OR ‫ס‬ 0.6; 95% CI ‫ס‬ 0.4-0.8) and gastric cardia (OR ‫ס‬ 0.6; 95% CI ‫ס‬ 0.5-0.9) as well as a reduced risk of esophageal squamous cell carcinoma (OR ‫ס‬ 0.6; 95% CI ‫ס‬ 0.4-0.9) and of noncardia gastric adenocarcinomas (OR ‫ס‬ 0.7; 95% CI ‫ס‬ 0.5-0.9). However, there was no apparent trend in risk with increasing number of drinks of wine per week.
Also shown in Table 4 are the risks associated with a combined estimate of alcohol consumption in comparison with never use of any type of alcohol. Risk in relation to total alcohol intake was decreased 30% (OR ‫ס‬ 0.7; 95% CI ‫ס‬ 0.5-1.0) for esophageal adenocarcinoma, 30% (OR ‫ס‬ 0.7; 95% CI ‫ס‬ 0.5-1.1) for gastric cardia adenocarcinoma, and 20% (OR ‫ס‬ 0.8; 95% CI ‫ס‬ 0.6-1.1) for nongastric cardia adenocarcinomas; however, none of the reductions in risk was statistically significant. In contrast, the risk of esophageal squamous cell carcinoma was significantly elevated 3.5-fold (OR ‫ס‬ 3.5; 95% CI ‫ס‬ 1.9-6.2) for ever versus never users of any alcoholic beverage; this risk increased with rising levels of intake reaching an OR of 7.4 (95% CI ‫ס‬ 4.0-13.7) among those who consumed more than 30 alcoholic drinks per week.
Since the patterns of risk observed in this study were similar for adenocarcinomas of the esophagus and gastric cardia, the cases were combined for additional analyses (Table 5 ). Risk associations with the highest levels of income and education, compared with the lowest, were decreased (OR ‫ס‬ 0.6; 95% CI ‫ס‬ 0.4-1.1 and 0.7; 95% ‫ס‬ 0.4-1.3, respectively), but the re- ductions were not statistically significant. A greater than twofold increase in risk was associated with ever smoking of cigarettes, which persisted up to 30 years after quitting. Attributable risk calculations revealed that 41% of all esophageal and gastric cardia adenocarcinomas combined are attributable to cigarette smoking (data not shown). As also shown in Table 5 , there was no association between adenocarcinomas of the esophagus and gastric cardia and the consumption of beer or liquor, but a reduction in risk was seen with ever drinking of wine (OR ‫ס‬ 0.6; 95% CI ‫ס‬ 0.5-0.8).
There was little heterogeneity in the ORs for esophageal and gastric cardia adenocarcinomas combined, or for the other tumor types, in relation to smoking, drinking, or socioeconomic status across subgroups categorized by age, sex, geographic center, or race (data not shown). Table 6 shows the estimates of risk for the four tumor types in relation to cigarette smoking stratified by alcohol drinking. The adjusted ORs for subjects who both smoked and drank were not substantially different from those who just smoked. Although the risk of esophageal squamous cell carcinoma more than doubled among smokers and wine drinkers (OR ‫ס‬ 6.8; 95% CI ‫ס‬ 2.2-21.1) compared with just smokers (OR ‫ס‬ 2.8; 95% CI ‫ס‬ 1.5-5.3), the apparent effect modification was not statistically significant (P ‫ס‬ .39).
The statistical analyses were repeated using a sample restricted to only subjects who were interviewed directly, i.e., excluding subjects with proxy respondents (data not shown). In this restricted sample, the risk estimates for the four tumor types in relation to smoking and drinking varied little from those obtained in analyses that included all participants. Thus, only the analyses based on the entire sample are presented.
Discussion
In this examination of tobacco, alcohol, and socioeconomic factors, we found similar estimates of effect for the development of esophageal and gastric cardia adenocarcinomas. When the two tumor types were combined, risk was reduced 40% in relation to an income of $75 000 or more and reduced 30% in relation to a graduate school education. Risk was increased 2.4 times in relation to currently smoking cigarettes, but it was unaffected by alcohol drinking, except for a 40% decrease associated with wine drinking. Risk estimates associated with income, education, and smoking status were similar in direction to those observed for the development of noncardia gastric adenocarcinomas and esophageal squamous cell carcinoma, although the risks were higher for the development of esophageal squamous cell carcinoma. The risk associated with wine consumption was reduced for all tumor types in our study, but the risks for beer and liquor intake were elevated twofold and threefold, respectively, for the development of esophageal squamous cell carcinoma. To our knowledge, this investigation is the largest population-based study of esophageal and gastric adenocarcinomas conducted to date. The study encompassed all incident cases of cancer of the esophagus and stomach identified in three geographic areas of the United States, with a standardized review of pathology specimens and medical records to assign the site of tumor origin and to confirm the histologic type. A comprehensive, personal questionnaire, which was administered by trained interviewers, was employed in the data collection. Despite this systematic approach, some limitations of the study must be considered when interpreting our results.
One problem relates to the difficulty of determining the exact site of origin for tumors arising near the gastro-esophageal junction. Thus, it is possible that misclassification of adenocarcinomas of the lower esophagus and the gastric cardia may contribute to the similar patterns of risk noted for these tumors.
Although the incidence rates for esophageal and gastric adenocarcinomas have risen dramatically over time, these tumors are still relatively uncommon, which limits our ability to identify subgroup effects. To maximize study efficiency, the comparison case subjects (i.e., those with esophageal squamous cell carcinoma or noncardia gastric adenocarcinomas) were frequency matched to the expected distribution of the target case subjects (i.e., those with esophageal and gastric cardia adenocarcinomas) on the basis of age and geographic area at all three centers; on the basis of sex in New Jersey and Washington; and on the basis of race in New Jersey. Because comparison cases were matched to target cases on the basis of race (and incidence rates for these latter tumors are higher among whites than among blacks), the comparison case subjects in our study do not reflect the underlying distributions for all cases of esophageal squamous cell carcinoma or noncardia gastric adenocarcinomas, for which incidence rates are substantially higher among blacks than among whites.
Approximately 30% of our case subject interviews were conducted with a proxy respondent whose knowledge of the exposure status of the case subject may be incomplete (26) . However, it is reassuring that analyses restricted to subjects with selfreports yielded results similar to analyses for all study participants, including those with next-of-kin interviews. Others (27) have also found that use of proxy-reported responses for cigarette smoking do not yield substantially biased estimates.
Our findings from this large case-control study are consistent with earlier population-based studies (13, 15) implicating cigarette smoking as a risk factor for esophageal and gastric cardia adenocarcinomas. The 140% increase in risk among current smokers observed in our data was not as great as that observed for squamous cell carcinoma of the esophagus, but it was slightly higher than the excess risk observed for adenocarcinomas of the lower stomach. It is noteworthy that the risk for esophageal and gastric cardia adenocarcinomas among exsmokers persisted at this elevated level for more than 20 years. On the basis of attributable risk calculations, 41% of all esophageal and gastric cardia adenocarcinomas in the three study areas is attributable to cigarette smoking. No decline in the risk of esophageal and gastric cardia adenocarcinomas was evident until 30 years after smoking cessation, which is in contrast to the steady decrease in risk observed after quitting for esophageal squamous cell carcinoma. These patterns suggest that smoking may affect an early stage in the induction of esophageal and gastric cardia adenocarcinomas, whereas later stages are involved for esophageal squamous cell carcinoma. As a result, the time trends in smoking prevalence may have contributed to the divergent incidence trends for these tumors. Thus, the declining incidence of esophageal squamous cell carcinoma since the 1970s is consistent with the reduced prevalence of cigarette smoking among American men that began in the 1960s. On the other hand, the rise in the prevalence of smoking among American men from the early part of this century until the 1960s, allowing for a lag of 30 years, coincides with the rising incidence of esophageal and gastric cardia adenocarcinomas, at least among older age groups. The recent national decline in smoking prevalence may not yet have had an impact on the trends for esophageal and gastric adenocarcinomas.
Although our study found no excess risk of esophageal and gastric cardia adenocarcinomas associated with the consumption of beer or hard liquor, there was an inverse association seen for wine drinking that extended to all four tumor types. If the reduction in risk is real, there may be a protective ingredient in wine, such as resveratrol (28) , that is not present in beer or liquor. However, previous population-based case-control studies in the United States (13, 15) have generally found no association between wine drinking and the risk of esophageal and gastric cardia adenocarcinomas. In comparison with these studies, the prevalence of wine consumption in our population-based control subjects appears to have been elevated, and it was higher among those who were male, white, and younger in age and who also reported a higher income, education, and intake of beer and liquor (data not shown). Thus, it is possible that the reduced risks associated with wine intake in our study are the result of sampling bias or perhaps of residual confounding.
Among persons in our study who reported both smoking cigarettes and drinking any type of alcohol, risk was not substantially greater for developing adenocarcinomas of the esophagus, the gastric cardia, or other gastric sites than for individuals who only reported smoking. The smoking-associated risk of esophageal squamous cell carcinoma, however, was more than twice as high among drinkers of any type of alcohol than among nondrinkers, which is consistent with other studies of this tumor (29) .
Our finding of a reduced risk of esophageal and gastric cardia adenocarcinomas among those with higher income levels confirms the results of earlier studies that were population-based and conducted in the United States (13, 15) . The findings for education, however, are inconsistent. Whereas Brown et al. In summary, our large population-based, case-control study of esophageal and gastric cardia adenocarcinomas revealed a doubling of risk among current and ex-smokers, a risk that persisted for nearly 30 years after smoking cessation, and a nonsignificant decrease in risk associated with higher incomes. No association was noted for beer or hard liquor intake, but a 40% reduced risk was associated with wine drinking. These patterns were similar to those observed for noncardia gastric adenocarcinomas. In contrast, the risks of developing esophageal squamous cell carcinoma were estimated to be more than five times higher among current smokers, 2.8-times higher among exsmokers, and more than three times higher among liquor drinkers. Our findings suggest that smoking affects an early stage in the development of esophageal and gastric adenocarcinomas and may have contributed to the recent increases reported in the incidence of these tumors, especially among older persons. Table 6 . Adjusted* odds ratios (ORs) and 95% confidence intervals (CIs) for esophageal adenocarcinoma, gastric cardia adenocarcinoma, esophageal squamous cell carcinoma, other gastric adenocarcinomas in relation to cigarette smoking and according to beer, liquor, and wine consumption 
